Dinan Katherine, Dinan Timothy G
School of Medicine, Trinity College, DO2PN40 Dublin, Ireland.
APC Microbiome Ireland and Department of Psychiatry, University College Cork, T12CY82 Cork, Ireland.
Pathogens. 2022 Jul 14;11(7):796. doi: 10.3390/pathogens11070796.
The gut microbiota is a virtual organ which produces a myriad of molecules that the brain and other organs require. Humans and microbes are in a symbiotic relationship, we feed the microbes, and in turn, they provide us with essential molecules. Bacteroidetes and Firmicutes phyla account for around 80% of the total human gut microbiota, and approximately 1000 species of bacteria have been identified in the human gut. In adults, the main factors influencing microbiota structure are diet, exercise, stress, disease and medications. In this narrative review, we explore the involvement of the gut microbiota in Parkinson's disease, Alzheimer's disease, multiple sclerosis and autism, as these are such high-prevalence disorders. We focus on preclinical studies that increase the understanding of disease pathophysiology. We examine the potential for targeting the gut microbiota in the development of novel therapies and the limitations of the currently published clinical studies. We conclude that while the field shows enormous promise, further large-scale studies are required if a causal link between these disorders and gut microbes is to be definitively established.
肠道微生物群是一个虚拟器官,它能产生大脑和其他器官所需的无数分子。人类与微生物处于共生关系,我们为微生物提供食物,反过来,它们为我们提供必需的分子。拟杆菌门和厚壁菌门约占人类肠道微生物群总数的80%,在人类肠道中已鉴定出约1000种细菌。在成年人中,影响微生物群结构的主要因素是饮食、运动、压力、疾病和药物。在这篇叙述性综述中,我们探讨了肠道微生物群在帕金森病、阿尔茨海默病、多发性硬化症和自闭症中的作用,因为这些都是高发性疾病。我们关注临床前研究,以增进对疾病病理生理学的理解。我们研究了在新型疗法开发中针对肠道微生物群的潜力以及当前已发表的临床研究的局限性。我们得出结论,虽然该领域显示出巨大的前景,但如果要明确确立这些疾病与肠道微生物之间的因果联系,还需要进一步的大规模研究。